Johnson & Johnson - 46 Year Dividend Yield History | JNJ

Historical dividend payout and yield for Johnson & Johnson (JNJ) since 1972. The current TTM dividend payout for Johnson & Johnson (JNJ) as of October 17, 2018 is $3.60. The current dividend yield for Johnson & Johnson as of October 17, 2018 is 2.64%.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $366.377B $76.450B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Pfizer (PFE) United States $261.509B 15.31
Novartis AG (NVS) Switzerland $198.652B 17.04
Merck (MRK) United States $192.023B 16.96
AbbVie (ABBV) United States $139.177B 13.60
Eli Lilly (LLY) United States $119.245B 22.07
Sanofi (SNY) France $111.234B 14.08
Novo Nordisk (NVO) Denmark $106.025B 16.95
AstraZeneca (AZN) United Kingdom $98.986B 10.89
GlaxoSmithKline (GSK) United Kingdom $98.701B 13.18
Bristol-Myers Squibb (BMY) United States $94.525B 17.11